SCHEMBL20936748

SCHEMBL20936748

Nc1ccc(N2CC[C@H](F)C2)nn1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 3/20 0.39
CHRNA4 P43681 3/20 0.39
CHRNB4 P30926 2/20 0.39
CHRNA3 P32297 2/20 0.39
MAP4K4 O95819 2/20 0.37
HRH4 Q9H3N8 2/20 0.36
CDK4 P11802 1/20 0.36
LMNA P02545 1/20 0.36
HTT P42858 1/20 0.36
CHRM3 P20309 1/20 0.36
PDE4A P27815 1/20 0.36
PDE4B Q07343 1/20 0.36
PDE4C Q08493 1/20 0.36
PDE4D Q08499 1/20 0.36
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
KLF5 Q13887 1/20 0.35
PDE10A Q9Y233 1/20 0.35
HTR3E A5X5Y0 1/20 0.35
MEN1 O00255 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20037485 0.84 PTPN11 (0.37) CHRNB2CHRNA4CHRNB4CHRNA3HRH4
SCHEMBL20037487 0.84 PTPN11 (0.37) CHRNB2CHRNA4CHRNB4CHRNA3HRH4
SCHEMBL20037483 0.83 PIK3CA (0.37) CHRNB2CHRNA4CHRNB4CHRNA3MAP4K4
SCHEMBL13768874 0.81 SMPD3 (0.40) CHRNB2CHRNA4CHRNB4CHRNA3CDK4
SCHEMBL18291535 0.81 SMPD3 (0.40) CHRNB2CHRNA4CHRNB4CHRNA3CDK4
SCHEMBL18291514 0.79 MAP4K4 (0.37) CHRNB2CHRNA4CHRNB4CHRNA3MAP4K4
SCHEMBL20037484 0.79 NMT1 (0.37) HRH4HRH3
SCHEMBL18291073 0.79 HRH4 (0.36) CHRNB2CHRNA4CHRNB4CHRNA3HRH4
SCHEMBL18291518 0.79 MAP4K4 (0.37) CHRNB2CHRNA4CHRNB4CHRNA3MAP4K4
SCHEMBL20255186 0.79 NMT1 (0.37) HRH4HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019079783-A1 ANTAGONISTS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4 VANDERBILT UNIVERSITY (US) 2019-04-25 WO disclosed